设为首页 加入收藏

TOP

MINIMS* BENOXINATE HYDROCHLORIDE 0,4%
2014-10-08 10:15:11 来源: 作者: 【 】 浏览:841次 评论:0
MINIMS* BENOXINATE HYDROCHLORIDE 0,4%

0504143

SCHEDULING STATUS:
Schedule 4

PROPRIETARY NAME
(and dosage form):

MINIMS* BENOXINATE HYDROCHLORIDE 0,4%
Eye Drops

COMPOSITION:
(per dispensing unit of 0,5mL)
Benoxinate Hydrochloride 2mg

PHARMACOLOGICAL CLASSIFICATION:
A 15.4 Ophthalmic preparations: other

PHARMACOLOGICAL ACTION:
Benoxinate hydrochloride is an effective surface anaesthetic which acts by blocking sensory nerve endings near the site of application. The solution produces little conjunctival irritation or hyperaemia and has no effect on the pupil; it has a bacteriostatic action and reduces the risk of exposure keratitis.

INDICATIONS:
Used in applanation tonometry and for the fitting of contact lenses.

CONTRA-INDICATIONS:
Caution should be observed when benoxinate hydrochloride is used in patients with allergies, cardiac disease, hyperthyroidism, or open lesions.

DOSAGE AND DIRECTIONS FOR USE:
Adults and children: To be used as directed by the ophthalmologist. 1-3drops of 0,4% solution, depending on the degree of anaesthesia required. Onset of action is 6-20seconds and duration of effect is 15minutes.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Systemic toxicity is rarely seen following ocular administration, but is identical to that for amethocaine hydrochloride; namely cardiovascular collapse due to idiosyncrasy and occasionally, convulsions and hyperexcitability.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
Not applicable.

IDENTIFICATION:
Clear, colourless solution.

PRESENTATION:
Sterile, single-dose disposable eye drops in cartons of 20units, each containing approximately 0,5mL.

STORAGE INSTRUCTIONS:
Store in the refrigerator between 2-8°C protected from strong light. DO NOT FREEZE. KEEP OUT OF REACH OF CHILDREN.

REGISTRATION NUMBER:
C/15.4/44

NAME AND BUSINESS ADDRESS OF APPLICANT:
Smith & Nephew Pharmaceuticals (Pty) Ltd
30 Gillitts Road
Pinetown 3610

Manufactured by:
Chauvin Pharmaceuticals Ltd.
Romford RM3 8SL, England

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
February 1, 2000

* Trademark

PMBHT04ZA

Updated on this site: December 2001 
以下是“全球医药”详细资料
Tags: 责任编辑:admin
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇BETAGAN 0,5% Liquifilm Sterile .. 下一篇LEANOR ARTICHOKE COMPOSTA (tabl..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位